These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1526 related articles for article (PubMed ID: 24470059)

  • 21. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
    Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
    Palmer SC; Craig JC; Navaneethan SD; Tonelli M; Pellegrini F; Strippoli GF
    Ann Intern Med; 2012 Aug; 157(4):263-75. PubMed ID: 22910937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
    Ballinger AE; Palmer SC; Nistor I; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2014; 2014(12):CD006254. PubMed ID: 25490118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.
    Strippoli GF; Navaneethan SD; Johnson DW; Perkovic V; Pellegrini F; Nicolucci A; Craig JC
    BMJ; 2008 Mar; 336(7645):645-51. PubMed ID: 18299289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for preventing bone disease in kidney transplant recipients.
    Palmer SC; Chung EY; McGregor DO; Bachmann F; Strippoli GF
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD005015. PubMed ID: 31637698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
    Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD; Shrivastava R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004289. PubMed ID: 15495097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
    Montero N; Webster AC; Royuela A; Zamora J; Crespo Barrio M; Pascual J
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD007669. PubMed ID: 25220222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.
    Karpe KM; Talaulikar GS; Walters GD
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006750. PubMed ID: 28730648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet agents for chronic kidney disease.
    Natale P; Palmer SC; Saglimbene VM; Ruospo M; Razavian M; Craig JC; Jardine MJ; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD008834. PubMed ID: 35224730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
    Sanders RD; Nicholson A; Lewis SR; Smith AF; Alderson P
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009971. PubMed ID: 23824754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone antagonists for preventing the progression of chronic kidney disease.
    Bolignano D; Palmer SC; Navaneethan SD; Strippoli GF
    Cochrane Database Syst Rev; 2014 Apr; (4):CD007004. PubMed ID: 24782282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
    Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011094. PubMed ID: 30019765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
    Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.
    Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010253. PubMed ID: 24901467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 77.